Trial Profile
The efficacy of a new long-acting insulin degludec in patient with diabetes
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 Aug 2015
Price :
$35
*
At a glance
- Drugs Insulin degludec (Primary)
- Indications Diabetes mellitus
- Focus Therapeutic Use
- 23 Aug 2015 Status changed from recruiting to active, no longer recruiting, as reported by University Hospital Medical Information Network - Japan.
- 02 Sep 2013 New trial record